肝细胞癌：手术治疗和不断发展的疗法。

Q2 Medicine

Cancer treatment and research Pub Date : 2024-01-01 DOI:10.1007/978-3-031-61238-1_10

Emanuel Eguia, Talia Baker, Marshall Baker

{"title":"肝细胞癌：手术治疗和不断发展的疗法。","authors":"Emanuel Eguia, Talia Baker, Marshall Baker","doi":"10.1007/978-3-031-61238-1_10","DOIUrl":null,"url":null,"abstract":"Hepatocellular carcinoma (HCC) is the fifth most common cancer in men and the eighth most common cancer in women worldwide. It is also the second leading cause of cancer death worldwide, with 780,000 deaths in 2018. Seventy-two percent of HCC cases occur in Asia, 10% in Europe, 8% in Africa, 5% in North America, and 5% in Latin America (Singal et al. in J Hepatol 72(2):250-261, 2020 [1]).","PeriodicalId":9486,"journal":{"name":"Cancer treatment and research","volume":"192 ","pages":"185-206"},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Hepatocellular Carcinoma: Surgical Management and Evolving Therapies.\",\"authors\":\"Emanuel Eguia, Talia Baker, Marshall Baker\",\"doi\":\"10.1007/978-3-031-61238-1_10\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Hepatocellular carcinoma (HCC) is the fifth most common cancer in men and the eighth most common cancer in women worldwide. It is also the second leading cause of cancer death worldwide, with 780,000 deaths in 2018. Seventy-two percent of HCC cases occur in Asia, 10% in Europe, 8% in Africa, 5% in North America, and 5% in Latin America (Singal et al. in J Hepatol 72(2):250-261, 2020 [1]).\",\"PeriodicalId\":9486,\"journal\":{\"name\":\"Cancer treatment and research\",\"volume\":\"192 \",\"pages\":\"185-206\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cancer treatment and research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1007/978-3-031-61238-1_10\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer treatment and research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/978-3-031-61238-1_10","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

摘要

肝细胞癌（HCC）是全球男性第五大最常见癌症，女性第八大最常见癌症。它也是全球第二大癌症死因，2018年有78万人死于此病。72%的 HCC 病例发生在亚洲，10%发生在欧洲，8%发生在非洲，5%发生在北美，5%发生在拉丁美洲（Singal 等人，载于《J Hepatol》72（2）：250-261，2020 [1]）。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Hepatocellular Carcinoma: Surgical Management and Evolving Therapies.

Hepatocellular carcinoma (HCC) is the fifth most common cancer in men and the eighth most common cancer in women worldwide. It is also the second leading cause of cancer death worldwide, with 780,000 deaths in 2018. Seventy-two percent of HCC cases occur in Asia, 10% in Europe, 8% in Africa, 5% in North America, and 5% in Latin America (Singal et al. in J Hepatol 72(2):250-261, 2020 [1]).

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Cancer treatment and research Medicine-Oncology

CiteScore

1.00

自引率

0.00%

发文量